TrialClinical cancer research : an official journal of the American Association for Cancer Research2026

Axicabtagene Ciloleucel in Combination with Atezolizumab in Patients with Refractory Diffuse Large B-Cell Lymphoma: The Phase 1/2 ZUMA-6 Trial.

Caron A Jacobson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.